Fox Chase Cancer Center

Oncology & Cancer

Protein tied to cancer drug resistance in mice

Blocking a specific protein renders tumors more vulnerable to treatment in mice, suggesting new therapies could eventually achieve the same in humans, according to new research from Fox Chase Cancer Center to be presented ...

Oncology & Cancer

Attitudes predict ability to follow post-treatment advice

Women are more likely to follow experts' advice on how to reduce their risk of an important side effect of breast cancer surgery—like lymphedema—if they feel confident in their abilities and know how to manage stress, ...

Oncology & Cancer

Routine blood test predicts prognosis in aggressive skin cancer

A routine blood test may help predict survival in patients with an aggressive form of skin cancer known as Merkel cell carcinoma, according to new findings by Fox Chase Cancer Center researchers. The results will be presented ...

Oncology & Cancer

Age tied to spread of rectal cancer to lymph nodes

Rectal cancer is more likely to spread to the lymph nodes in younger patients, according to new findings that Fox Chase Cancer Center researchers will be presenting on October 29 at the American Society for Radiation Oncology's ...

Oncology & Cancer

Drop in testosterone tied to prostate cancer recurrence

Men whose testosterone drops following radiation therapy for prostate cancer are more likely to experience a change in PSA levels that signals their cancer has returned, according to new research from Fox Chase Cancer Center. ...

Oncology & Cancer

New therapy on the horizon for ALK+ non-small cell lung cancer

A new compound that targets anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer is well-tolerated by patients and is already showing early signs of activity, including in patients who no longer respond to ...

page 5 from 16